Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 36,240 shares at $119.96 ($4.3M) on 2021-01-26, disclosed to the SEC on 2021-01-27.
Open-market sale of $4.3M NBIX by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $119.95 | 8,958 | $1.1M | 24.7% |
| 2 | $119.95 | 8,958 | $1.1M | 24.7% |
| 3 | $119.98 | 4,601 | $552K | 12.7% |
| 4 | $119.98 | 4,601 | $552K | 12.7% |
| 5 | $119.98 | 4,011 | $481K | 11.1% |
| 6 | $119.98 | 4,011 |
| $481K |
| 11.1% |
| 7 | $119.96 | 500 | $60K | 1.4% |
| 8 | $119.98 | 600 | $72K | 1.7% |
| Total | $119.96 avg | 36,240 | $4.3M | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |